Neoadjuvant concurrent chemoradiotherapy using infusional gemcitabine in locally advanced rectal cancer: A phase II trial

INTRODUCTION: Gemcitabine is a well‐known radiosensitizer. Herein, we tested the efficacy and toxicity of preoperative concurrent infusional gemcitabine and radiotherapy in locally advanced rectal cancer. PATIENTS AND METHODS: This was a phase II, single‐arm trial. Eligible patients had a diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Bazarbashi, Shouki, Elshenawy, Mahmoud A., Badran, Ahmed, Aljubran, Ali, Alzahrani, Ahmed, Almanea, Hadeel, Alsuhaibani, Abdullah, Alashwah, Ahmed, Neimatallah, Mohamed, Abduljabbar, Alaa, Ashari, Luai, Alhomoud, Samar, Ghebeh, Hazem, Elhassan, Tusneem, Alsanea, Nasser, Mohiuddin, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119355/
https://www.ncbi.nlm.nih.gov/pubmed/35146939
http://dx.doi.org/10.1002/cam4.4590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119355/
https://www.ncbi.nlm.nih.gov/pubmed/35146939
http://dx.doi.org/10.1002/cam4.4590

Ejemplares similares